FDA Draft Guidance on Safety Data Collection for Late Stage Premarket & Postmarket Investigations (JSON)

lexblog.com/lib/PDA2ZFX0view recordjson

{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "FDA Draft Guidance on Safety Data Collection for Late Stage Premarket & Postmarket Investigations",
    "url": "https://www.lexblog.com/2012/03/14/fda-draft-guidance-on-safety-data-collection-for-late-stage-premarket-postmarket-investigations/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-PDA2ZFX0",
        "url": "https://www.lexblog.com/lib/PDA2ZFX0/"
    },
    "datePublished": "2012-03-14T13:03:43-04:00",
    "dateModified": "2022-07-22T19:29:12-04:00",
    "author": {
        "@type": "Person",
        "name": "Celeste Letourneau"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Reed Smith LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Health Industry Washington Watch",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "http://localhost/healthwatch/2012/03/14/fda-draft-guidance-on-safety-data-collection-for-late-stage-premarket-postmarket-investigations/",
    "sourceStability": "may-move"
}